FEBS J. 2017 Jan;284(2):218-221. doi: 10.1111/febs.13997.
Targeting a metabolic pathway to fight the flu.
Boergeling Y1, Ludwig S1.
Author information
Abstract
Our antiviral arsenal to fight influenza viruses is limited and we need novel anti-flu drugs. Recently, cellular drug targets came into focus and omics analysis were instrumental to suggest candidate factors. In this issue of The FEBS Journal, Kainov and colleagues used transcriptome data to investigate virus-induced changes in tryptophan metabolism that may serve as immunomodulatory approach against viruses.
? 2017 Federation of European Biochemical Societies.
PMID: 28121076 DOI: 10.1111/febs.13997
[PubMed - in process]
Targeting a metabolic pathway to fight the flu.
Boergeling Y1, Ludwig S1.
Author information
Abstract
Our antiviral arsenal to fight influenza viruses is limited and we need novel anti-flu drugs. Recently, cellular drug targets came into focus and omics analysis were instrumental to suggest candidate factors. In this issue of The FEBS Journal, Kainov and colleagues used transcriptome data to investigate virus-induced changes in tryptophan metabolism that may serve as immunomodulatory approach against viruses.
? 2017 Federation of European Biochemical Societies.
PMID: 28121076 DOI: 10.1111/febs.13997
[PubMed - in process]
Comment